Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RTM
|
||||
Former ID |
DNCL002877
|
||||
Drug Name |
LEZ763
|
||||
Indication | Peripheral arterial disease; Type 2 diabetes [ICD9: 443, 250; ICD10:I73, E11] | Phase 1/2 | [523944] | ||
Company |
Novartis
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Modulator | ||
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.